• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

类紫杉醇脂质体体外释放的桨膜结合分析法研究

郑玉婷, 洪涛, 徐柯卉, 温明皓, 杨吉雪, 伍梦莹, 杭太俊, 宋敏

郑玉婷, 洪涛, 徐柯卉, 温明皓, 杨吉雪, 伍梦莹, 杭太俊, 宋敏. 类紫杉醇脂质体体外释放的桨膜结合分析法研究[J]. 中国药科大学学报, 2023, 54(6): 743-748. DOI: 10.11665/j.issn.1000-5048.2023041803
引用本文: 郑玉婷, 洪涛, 徐柯卉, 温明皓, 杨吉雪, 伍梦莹, 杭太俊, 宋敏. 类紫杉醇脂质体体外释放的桨膜结合分析法研究[J]. 中国药科大学学报, 2023, 54(6): 743-748. DOI: 10.11665/j.issn.1000-5048.2023041803
shu
ZHENG Yuting, HONG Tao, XU Kehui, WEN Minghao, YANG Jixue, WU Mengying, HANG Taijun, SONG Min. In vitro release of paclitaxel derivative liposome by paddle membrane binding assay[J]. Journal of China Pharmaceutical University, 2023, 54(6): 743-748. DOI: 10.11665/j.issn.1000-5048.2023041803
Citation: ZHENG Yuting, HONG Tao, XU Kehui, WEN Minghao, YANG Jixue, WU Mengying, HANG Taijun, SONG Min. In vitro release of paclitaxel derivative liposome by paddle membrane binding assay[J]. Journal of China Pharmaceutical University, 2023, 54(6): 743-748. DOI: 10.11665/j.issn.1000-5048.2023041803
shu

类紫杉醇脂质体体外释放的桨膜结合分析法研究

  • 中国药科大学药物分析系，南京 210009

In vitro release of paclitaxel derivative liposome by paddle membrane binding assay

  • Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009, China

摘要

    摘要
  • 摘要: 体外释放度是评价脂质体制剂质量的重要指标，目前各国药典中均未收载脂质体体外释放度评价方法，致使脂质体质量评价缺乏统一标准和无法提供安全性保障。本研究以自制类紫杉醇脂质体为例，通过优化外部释放条件建立的桨膜结合法模拟了在生理条件下类紫杉醇药物12 h的释放情况，结果表明以0.5% SDS-HEPES作为释放介质，采用截留分子量为1 000 kD的透析袋对脂质体水溶液进行释放的结果满足要求，且具有区分能力，为载药脂质体体外释放方法开发提供参考。
    Abstract: The in vitro release is an important index to evaluate the quality of liposome formulation.Currently, there is no evaluation method for the in vitro release of liposome in pharmacopoeia of various countries, which leads to the lack of unified standard and safety guarantee for the quality evaluation of liposome formulation.Taking the self-made paclitaxel derivative liposomes as an example, the paddle membrane binding method established by optimizing external release conditions was used to simulate the complete release of paclitaxel derivative drugs in 12 hours under physiological conditions.The results showed that using 0.5% SDS-HEPES as the release medium and a dialysis bag with a molecular weight cutoff of 1 000 kD to release the liposome solution met the requirements and had discrimination ability, providing a reference for the development of drug-loaded liposomes release methods in vitro.
    • HTML全文
    • 参考文献(23)
  • [1] U.S. Food and Drug Administration. extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations[EB/OL]. (1997-09-01) [2023-03-27] https://www.fda.gov/regulatory-information/search-fda-guidance-documents/extended-release-oral-dosage-forms-development-evaluation-and-application-vitroin-in-vivo-correlations.
    [2] Bhardwaj U, Burgess DJ. A novel USP apparatus 4 based release testing method for dispersed systems[J]. Int J Pharm, 2010, 388(1/2): 287-294.
    [3] Liu Y, Zhang YJ, Wang ZY, et al. Research progress in bioanalysis and pharmacokinetics of liposome nanomedicine[J]. Acta Pharm Sin (药学学报), 2023, 58(4): 834-843.
    [4] Skoczen SL, Snapp KS, Crist RM, et al. Distinguishing pharmacokinetics of marketed nanomedicine formulations using a stable isotope tracer assay[J]. ACS Pharmacol Transl Sci, 2020, 3(3): 547-558.
    [5] Varache M, Ciancone M, Couffin AC. Optimization of a solid-phase extraction procedure for the analysis of drug-loaded lipid nanoparticles and its application to the determination of leakage and release profiles[J]. J Pharm Sci, 2020, 109(8): 2527-2535.
    [6] Xu XM, Khan MA, Burgess DJ. A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes[J]. Int J Pharm, 2012, 426(1/2): 211-218.
    [7] Magar KT, Boafo GF, Li XT, et al. Liposome-based delivery of biological drugs[J]. Chin Chem Lett (中国化学快报), 2022, 33(2): 587-596.
    [8] Wang S, Li WX, Sun KY, et al. Study of release kinetics and degradation thermodynamics of ferric citrate liposomes[J]. Chem Phys Lipids, 2019, 225: 104811.
    [9] Alavi S, Mahjoob MA, Haeri A, et al. Multivesicular liposomal depot system for sustained delivery of risperidone: development, characterization, and toxicity assessment[J]. Drug Dev Ind Pharm, 2021, 47(8): 1290-1301.
    [10] Tefas LR, Toma I, Sesarman A, et al. Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer[J]. J Liposome Res, 2023, 33(3): 234-250.
    [11] Wang B, Xu QQ, Zhou CJ, et al. Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma[J]. Acta Biochim Pol, 2021, 68(4): 711-715.
    [12] Hasan MM, Hamiduzzaman M, Jahan I, et al. Formulation development, characterization and In-vitro evaluation of tamoxifen loaded liposomes[J]. J Pharm Res Int, 2020,32(6): 64-82.
    [13] Shah H, Madni A, Khan MM, et al. pH-responsive liposomes of dioleoyl phosphatidylethanolamine and cholesteryl hemisuccinate for the enhanced anticancer efficacy of cisplatin[J]. Pharmaceutics, 2022, 14(1): 129.
    [14] Khan S, Madni A, Rahim MA, et al. Enhanced in vitro release and permeability of glibenclamide by proliposomes: development, characterization and histopathological evaluation[J]. J Drug Deliv Sci Technol, 2021, 63: 102450.
    [15] Modi S, Anderson BD. Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method[J]. Mol Pharm, 2013, 10(8): 3076-3089.
    [16] Dubatouka K, Agabekov V. Preparation and characterization of tissue plasminogen activator-loaded liposomes[J]. Soft Mater, 2022, 20(3): 358-363.
    [17] Wallace SJ, Li J, Nation RL, et al. Drug release from nanomedicines: selection of appropriate encapsulation and release methodology[J]. Drug Deliv Transl Res, 2012, 2(4): 284-292.
    [18] Regenold M, Steigenberger J, Siniscalchi E, et al. Determining critical parameters that influence in vitro performance characteristics of a thermosensitive liposome formulation of vinorelbine[J]. J Control Release, 2020, 328: 551-561.
    [19] O?uzhan Kaya H, Karpuz M, Nur Topkaya S. Electrochemical analysis of liposome-encapsulated colistimethate sodium[J]. Electroanalysis, 2022, 34(7): 1114-1120.
    [20] Yu YB, Huang YD, Feng WQ, et al. NIR-triggered upconversion nanoparticles@thermo-sensitive liposome hybrid theranostic nanoplatform for controlled drug delivery[J]. RSC Adv, 2021, 11(46): 29065-29072.
    [21] Heneweer C, Pe?ate Medina T, Tower R, et al. Acid-sphingomyelinase triggered fluorescently labeled sphingomyelin containing liposomes in tumor diagnosis after radiation-induced stress[J]. Int J Mol Sci, 2021, 22(8): 3864.
    [22] Janas C, Mast MP, Kirsamer L, et al. The dispersion releaser technology is an effective method for testing drug release from nanosized drug carriers[J]. Eur J Pharm Biopharm, 2017, 115: 73-83.
    [23] Wallenwein CM, Nova MV, Janas C, et al. A dialysis-based in vitro drug release assay to study dynamics of the drug-protein transfer of temoporfin liposomes[J]. Eur J Pharm Biopharm, 2019, 143: 44-50.
    • 相关文章
    • 施引文献
    • 资源附件(0)
计量
  • 文章访问数:  151
  • HTML全文浏览量:  16
  • PDF下载量:  244
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-04-17
  • 修回日期:  2023-12-05
  • 刊出日期:  2023-12-24

目录

摘要
HTML全文
    参考文献(23)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    版权所有：《中国药科大学学报》编辑部苏ICP备05007142号

    地址：江苏省南京市鼓楼区童家巷24号（210009）电话: 025-83271566E-mail: xuebao@cpu.edu.cn

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计

    访问量：365415

    x 关闭 永久关闭